Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss

NCT07303322 is registered in ClinicalTrials.gov with Eurofarma Laboratorios S.A. as lead sponsor.

NCT NCT07303322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07303322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss
Lead sponsor
Eurofarma Laboratorios S.A.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
August 31, 2028
Enrollment
372 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

female pattern hair loss, female pattern hair loss, androgenic alopecia